Clinical trials
Completed Prostatic Hyperplasia trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 3 |
| Boston Scientific Corporation | 2 |
| Fuzhou General Hospital | 2 |
| Chinese PLA General Hospital | 1 |
| Eli Lilly and Company | 1 |
| Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 1 |
| Hospital Authority, Hong Kong | 1 |
| Qing Yuan | 1 |
| REMD Medical Technology | 1 |
| Shanghai Changzheng Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Hyperplasia | 17 |
| Erectile Dysfunction | 2 |
| Lower Urinary Tract Symptoms | 2 |
| Lymphoma, Follicular | 1 |
| Prostatic Neoplasms | 1 |
| Urinary Incontinence, Stress | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.